Black Diamond Therapeutics (BDTX) EPS (Basic) (2018 - 2026)
Black Diamond Therapeutics' (BDTX) quarterly EPS (Basic) came in at -$0.2 in Q1 2026, down 120.85% YoY from $0.95 in Q1 2025, and up 35.65% on a QoQ basis from -$0.31 in Q4 2025.
Black Diamond Therapeutics (BDTX) EPS (Basic) (2018 - 2026) Analysis & Trends
Black Diamond Therapeutics (BDTX) has 9 years of EPS (Basic) data on file, last reported at -$0.2 in Q1 2026.
- Quarterly EPS (Basic) fell 120.85% year-over-year to -$0.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.0 (down 42.55% YoY) and the FY2025 annual result came in at -$1.89, up 48.99% from the prior year.
- EPS (Basic) improved to -$0.2 in Q1 2026, from -$0.31 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.95 in Q1 2025 to a low of -$1.58 in Q3 2022.
- A 5-year average of -$0.52 and a median of -$0.49 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2025 — EPS (Basic) jumped 338.72% — and 2026, when it plunged 120.85%.
- Tracing BDTX's EPS (Basic) over 5 years: stood at -$0.61 in 2022, then gained by 19.64% to -$0.49 in 2023, then surged by 30.44% to -$0.34 in 2024, then climbed by 9.68% to -$0.31 in 2025, then surged by 35.65% to -$0.2 in 2026.
- The last three EPS (Basic) figures came in at -$0.2 (Q1 2026), -$0.31 (Q4 2025), and -$0.27 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 0.18 |
| 10 | Black Diamond Therapeutics | 125.35 Mn | 14.84 Mn | - | -0.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.20 |
| Mar 31, 2026 | -0.20 |
| Dec 31, 2025 | -0.31 |
| Sep 30, 2025 | -0.27 |
| Jun 30, 2025 | -0.23 |
| Mar 31, 2025 | 0.95 |
| Dec 31, 2024 | -0.34 |
| Sep 30, 2024 | -0.44 |
| Jun 30, 2024 | -0.90 |
| Mar 31, 2024 | -0.40 |
| Dec 31, 2023 | -0.49 |
| Sep 30, 2023 | -1.08 |
| Jun 30, 2023 | -0.84 |
| Mar 31, 2023 | -0.60 |
| Dec 31, 2022 | -0.61 |
| Sep 30, 2022 | -1.58 |
| Jun 30, 2022 | -0.83 |
| Mar 31, 2022 | -0.72 |
| Dec 31, 2021 | -0.72 |
| Sep 30, 2021 | -1.19 |